BUTTERFLY NETWORK INC CLASS A (BFLY)
Health Care · medical devices / diagnostic imaging · NYSE
Butterfly Network provides portable, semiconductor-based ultrasound technology to make medical imaging more accessible and affordable globally.
What BUTTERFLY NETWORK INC CLASS A does
Butterfly Network is a digital health company focused on transforming medical imaging through its proprietary ultrasound-on-a-chip technology. The company develops and markets handheld, portable ultrasound devices and software platforms that integrate with mobile devices to provide diagnostic imaging capabilities.
Themes: point-of-care ultrasound, digital health, medical imaging hardware, mobile medical technology
Fundamentals
- Price$7.31 as of 2026-10-20 close
- Market cap$1.9B as of 2026-07-24 (share count; price 2026-10-20)
- 1-year return+209.7% 2025-10-20 close $2.36 → 2026-10-20 close $7.31
- P/En/a negative earnings
- Net margin-79.0% FY2025, SEC XBRL
- Gross margin+46.9% FY2025, SEC XBRL
- ROE-39.3% FY2025, SEC XBRL
- ROICn/a No figure: its pre-tax income was zero or negative, so there is no tax rate to apply.
- Debt / equityn/a No figure: its filing tags none of the debt lines we read, which is not evidence of zero debt.
- Revenue growth (YoY)+19.0% FY2025, SEC XBRL
- Revenue CAGR (3y)+10.0% SEC XBRL
- Beta2.58 as of 2026-09-03
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
How BFLY compares in its sector
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- gross marginmiddle range 189 covered Health Care peers, as of 2026-09-03
- return on equitymiddle range 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
BFLY is not currently in any published Top 10 list. Its scores are below.
Top 10 score
46.4 #945 of 1,379 scored · #116 of 152 in Health Care
Trend 79th (over the past 12 months this stock beat the market by 216.6 percentage points) and growth 73rd (revenue growth year over year 28.1%, 3-year revenue CAGR 10%); weakest is profitability (4th, return on equity -39.3%, operating margin -88.5%).
Scores as of 15 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4. BFLY was not in the scored universe at the latest run on 20 Oct 2026, so these scores are its last ones.
Quarterly results
| Quarter | Revenue | Gross profit | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $33M | $23M | -$14M | -$13M | -$0.05 | -$16M† | $974000† |
| Q1 FY2026 2026-03-31 | $27M | $18M | -$14M | -$13M | -$0.05 | -$14M | $950000 |
| Q4 FY2025 2025-12-31 | $32M† | $21M† | -$17M† | -$15M† | -$0.06† | $9M† | $1M† |
| Q3 FY2025 2025-09-30 | $21M | -$4M | -$35M | -$34M | -$0.13 | -$3M† | $1M† |
| Q2 FY2025 2025-06-30 | $23M | $15M | -$16M | -$14M | -$0.06 | -$7M† | $896000† |
| Q1 FY2025 2025-03-31 | $21M | $13M | -$18M | -$14M | -$0.06 | -$12M | $353000 |
| Q4 FY2024 2024-12-31 | $22M† | $14M† | -$17M† | -$18M† | -$0.08† | -$3M† | $408000† |
| Q3 FY2024 2024-09-30 | $21M | $12M | -$17M | -$17M | -$0.08 | -$8M† | $414000† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$125M
- Total debtnot shown the filing tags none of the debt lines we read — not evidence of zero debt
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How BUTTERFLY NETWORK INC CLASS A looks technically
BUTTERFLY NETWORK INC CLASS A (BFLY) is trading 23.5% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 224 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 20, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 41, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 10 trading days ago (its momentum flipped negative). It made a new 20-day low about 3 trading days ago. It is 28.4% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 23.5% above its 200-day average, the long-term trend line — a longer-term uptrend | +23.5% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $8.40 | $8.40 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $5.92 | $5.92 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a completed five-part upward sequence — the pattern Elliott-wave chartists call an impulse — which on that reading would now be due a pullback rather than more of the same; the labelling fails if price closes above 10.21. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible five-wave upward sequence, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 224 trading days ago — a "golden cross", a bullish long-term signal | 224 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 20, below the 25 that marks a real trend) | 19.8 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 41, neither overbought (above 70) nor oversold (below 30) | 40.8 |
|---|---|---|
| Position in its 14-day range | it is trading right at the bottom of its 14-day range ($7.22 to $10.21) — its "stochastic" reading is 3 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 3.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 10 trading days ago (its momentum flipped negative) | 10 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $10.21 | $10.21 |
|---|---|---|
| From the 52-week high | it is 28.4% below its 52-week high (its highest price of the past year) | -28.4% |
| Above the 52-week low | it is 284.7% above its 52-week low (its lowest price of the past year) | +284.7% |
| Below the 52-week high | it is 28.4% below its highest point of the past year | 28.4% |
| Since a 20-day breakout | it made a new 20-day low about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 21 trading days ago | 21 sessions |
| All-time high | its highest closing price on record is $29.13 (set on 2021-02-18) | $29.13 |
| Given back of the 52-week move | over the past year its closes ranged ($1.97 to $9.93), and it has given back roughly a third of its rise from last year’s low — 33% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $4.76 to $5.01. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 32.9% |
| From the all-time high | it is 74.9% below its all-time high | -74.9% |
| Nearest price level | it is trading 31.7% above a support level at $4.99 — a price it turned at three times since 2025-02-18, most recently on 2026-02-26. Since 2024-10-21 it has 15 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -31.7% |
| All-time low | its lowest closing price on record is $0.674 (set on 2024-04-25) | $0.674 |
| Above the all-time low | it is 984.6% above its all-time low | +984.6% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 76% of it) | 24th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.6045 between its high and its low — about 8.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.6045 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $7.07 and $9.88 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $7.07 – $8.47 – $9.88 |
| Typical daily range (% of price) | its price moves about 8.3% in a typical session — among the most volatile in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 8.3% |
| Stretch from the 200-day average | it is trading 2.3 daily ranges above its 200-day average price (23.5% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.63× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a hammer | 8 sessions ago, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | 8 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-20 0.1% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.1% |
|---|---|---|
| Open gap | it gapped 3.5% above the previous close 1 session ago and has not traded back through the level it left behind at 7.25 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +3.5% |
| Gap filled | a 2.8% gap down opened on 2026-10-14 has been "filled" 4 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 4 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 8.2 percentage points (the stock lost 7.2% while the market gained 1.0%) | -8.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 5.6 percentage points (the stock gained 9.3% while the market gained 3.6%) | +5.6% |
| vs market, 6 months | over the past 6 months this stock beat the market by 24.6 percentage points (the stock gained 33.2% while the market gained 8.5%) | +24.6% |
| vs market, 12 months | over the past 12 months this stock beat the market by 195.2 percentage points (the stock gained 209.7% while the market gained 14.6%) | +195.2% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a fresh 20-day low, MACD momentum is negative, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 10% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thin, spanning 0.5% of the share price, which is taken to mean a barrier that gives way easily. | -10.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 16% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $6.29 — a volume-weighted average of daily closes over 200 sessions, not a true tick-by-tick VWAP. | +16.2% |
|---|---|---|
| Vs the average paid since it last reported | the price is 14% below the average price paid since it last reported on 2026-07-30 (its 10-Q), so the typical buyer over that stretch is under water. That average is $8.51 — a volume-weighted average of daily closes over 58 sessions, not a true tick-by-tick VWAP. | -14.1% |
Double top, bearish — forming · entry $7.12 · 50 sessions in
Price levels it has turned at before
BFLY last closed at $7.31 on 2026-10-20. Since 2024-10-21 it has turned at 15 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $4.99 | Support | 31.7% below the last close | turned there three times · 2025-02-18 to 2026-02-26 |
| $9.69 | Resistance | 32.5% above the last close | turned there twice · 2026-06-29 to 2026-08-21 |
| $10.05 | Resistance | 37.5% above the last close | turned there twice · 2026-08-10 to 2026-09-23 |
| $4.43 | Support | 39.3% below the last close | turned there twice · 2025-01-03 to 2026-03-25 |
| $4.00 | Support | 45.3% below the last close | turned there twice · 2025-12-23 to 2026-01-20 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now complete.
This labelling fails — stops being a possible reading at all — if it closes above $10.21.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
This reading has stood for 15 trading days, since 2026-09-30.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Trading below the 50-day moving average · Pulled back from the 12-month high · Broke down to a new 20-day low · trendless / choppy (low ADX) · beating the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.14 mean, 1=Strong Buy…5=Strong Sell) — 6 analysts
- Mean price target$11.17 range $10.00 – $15.00; median $10.50
Analyst estimates, as of 2026-10-20. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for BFLY
- Consensus EPS estimate-$0.03 next reporting period, as of 2026-10-20
- Estimate change, 30 days$0.00 from -$0.03, on 2026-09-15, 35-day window
- Readings revised upward0% of 10 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Ongoing operating losses and the need to manage growth effectively in a competitive market.","Reliance on third-party manufacturing, licensing, and supply agreements.","Dependence on regulatory authorizations and evolving medical reimbursement policies."]
What changed in the latest 10-Q
AI-assisted comparison of BFLY's 10-Q filed 2026-07-30 against the prior one filed 2026-04-30.
Management's Discussion & Analysis (MD&A)
- Added:
- The newer filing (2026-07-30) includes the phrase 'our co-development partnership with Midjourney, Inc.' in the explanation for the increase in software and other services mix.
- The newer filing (2026-07-30) updates the KPI narrative to reference the three months ended June 30, 2026 compared to June 30, 2025.
- Removed:
- The older filing (2026-04-30) includes the explanation that the increase in units fulfilled was driven by higher probe sales volume in international distributor and veterinary sales channels, including the launch of the iQ3 Vet probe in the United States and some international markets in the fourth quarter of 2025; this language does not appear in the newer filing.
- Reworded:
- Units fulfilled: The newer filing (2026-07-30) states an increase of 1,176 units, or 22.5%, for the three months ended June 30, 2026 compared to June 30, 2025, driven by higher probe sales volume in the U.S. through direct sales to health systems and medical schools as well as the eCommerce sales channel. The older filing (2026-04-30) states an increase of 234 units, or 4.9%, for the three months ended March 31, 2026 compared to March 31, 2025, driven by higher probe sales volume in international distributor and veterinary sales channels.
- Software and other services mix: The newer filing (2026-07-30) states an increase of 22.9 percentage points, to 51.8%, for the three months ended June 30, 2026 compared to June 30, 2025, including mention of the Midjourney co-development partnership. The older filing (2026-04-30) states an increase of 11.5 percentage points, to 44.8%, for the three months ended March 31, 2026 compared to March 31, 2025.
- The older filing (2026-04-30) refers to 'Research and development expenses pri' as the closing text of the provided section, whereas the newer filing (2026-07-30) ends with 'Research and development expen'; both appear truncated and cannot be fully compared at that boundary.
- Notes:
- Both provided texts are truncated at the 'Research and development' description, so any changes after that point are not assessable.
- The comparison is limited to the section text supplied and may not reflect the full MD&A of either filing.
Risk Factors
- Added:
- In the newer filing (2026-07-30), Exhibit 10.1@ was added to the Exhibit Index: "Co-Development and Licensing Agreement, dated as of November 13, 2025, by and between BFLY Operations, Inc. and Midjourney, Inc." filed herewith.
- In the newer filing (2026-07-30), a footnote "@" was added after the Exhibit Index: "Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets ("[***]") because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed."
- Removed:
- In the older filing (2026-04-30), Item 5 contained a paragraph stating that on March 13, 2026, Dr. Jonathan Rothberg and entities owned by trusts for his children adopted a Rule 10b5-1 trading arrangement authorizing sale of up to 2,799,818 shares of Class A common stock and up to 5,000,000 shares of Class B common stock during the period beginning July 14, 2026 and ending July 14, 2027.
- Reworded:
- Item 2 in the newer filing (2026-07-30) states "the three months ended June 30, 2026" while the older filing (2026-04-30) states "the three months ended March 31, 2026."
- Item 5 in the newer filing (2026-07-30) states that during the three months ended June 30, 2026 none of the directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement. The older filing (2026-04-30) included the same statement for the three months ended March 31, 2026 but preceded it with the Rule 10b5-1 adoption disclosure regarding Dr. Rothberg and stated "none of our other directors or officers".
- The signature page date changed from April 30, 2026 in the older filing to July 30, 2026 in the newer filing.
- Notes:
- The extracted texts include material beyond the Risk Factors section (Items 2, 5, 6, exhibit indexes, and signature pages). The Risk Factors section language itself is identical between the two filings.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 17 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 5 days since 2026-10-16 have not been checked yet.
- Last 30 days · read to 2026-10-160 buys · 4 sells ($506929) — 2 selling insiders
- Last 90 days · read to 2026-10-161 buy ($999510) · 17 sells ($38M) — 1 buying, 5 selling insiders
- Last 180 days · read to 2026-10-161 buy ($999510) · 40 sells ($100M) — 1 buying, 8 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-10-06. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about BFLY's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
6 institutional 13F filers reported holding BFLY as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 36,011,601
- Reported value $303,217,677
reported quarterly holdings change (2026-03-31 → 2026-06-30): 1 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about BFLY's institutional holders → See what each manager we track holds →
Short interest (FINRA)
BFLY had 31,641,985 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for BFLY because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 31,641,985
- Prior settlement (shares) 35,727,812
- Reported change -11.44%
- Days to cover (reported) 4.79
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- GE HealthCare (GEHC)
- Philips (PHG)
- Siemens Healthineers (SMMNY)
- Fujifilm Sonosite
- Clarius Mobile Health
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare BFLY vs…
BUTTERFLY NETWORK INC CLASS A is found in…
Frequently asked questions
What does BUTTERFLY NETWORK INC CLASS A (BFLY) do?
Butterfly Network is a digital health company focused on transforming medical imaging through its proprietary ultrasound-on-a-chip technology. The company develops and markets handheld, portable ultrasound devices and software platforms that integrate with mobile devices to provide diagnostic imaging capabilities.
What sector is BUTTERFLY NETWORK INC CLASS A (BFLY) in?
BUTTERFLY NETWORK INC CLASS A (BFLY) is classified in the Health Care sector. Its industry is medical devices / diagnostic imaging. It trades on NYSE.
Who are BUTTERFLY NETWORK INC CLASS A's (BFLY) competitors?
Notable peers of BUTTERFLY NETWORK INC CLASS A (BFLY) include GE HealthCare, Philips, Siemens Healthineers, Fujifilm Sonosite and Clarius Mobile Health. This peer set is informational only — not financial advice.
Is BUTTERFLY NETWORK INC CLASS A (BFLY) overbought or oversold right now?
BUTTERFLY NETWORK INC CLASS A (BFLY) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 41, in the neutral middle (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on BFLY come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.